Solara Active Pharma Sciences Ltd Quarterly Results

Gross Sales

273.01

300.31

346.95

363.49

299.43

Excise Duty

0

0

0

0

0

Net Sales

273.01

300.31

346.95

363.49

299.43

Other Operating Income

0

0

0

0

0

Other Income

5.95

1.49

0.32

0.56

1.7

Total Income

278.96

301.8

347.27

364.05

301.13

Total Expenditure

227.64

242.63

285.64

321.57

411.85

PBIDT

51.32

59.17

61.63

42.48

-110.72

Interest

29.12

26.54

28.28

30.87

30.69

PBDT

22.2

32.63

33.35

11.61

-141.41

Depreciation

24.3

24.54

25.34

25.07

25.25

Minority Interest Before NP

0

0

0

0

0

Tax

0

0

0

0

0

Deferred Tax

0

0

0

0

88.79

Reported Profit After Tax

-2.1

8.09

8.01

-13.46

-255.45

Minority Interest After NP

0

0

0

0

-0.11

Net Profit after Minority Interest

-2.1

8.09

8.01

-13.46

-255.34

Extra-ordinary Items

0

0

0

0

-57.09

Adjusted Profit After Extra-ordinary item

-2.1

8.09

8.01

-13.46

-198.25

EPS (Unit Curr.)

-0.93

2.03

2.54

-3.5

-70.93

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

40.25

40.25

40.21

42

36

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

18.79

19.7

17.76

11.68

-36.97

PBDTM(%)

8.13

10.86

9.61

3.19

-47.22

PATM(%)

-0.76

2.69

2.3

-3.7

-85.31